Based on previous findings, we hypothesized that TOM-derived human metabolites mimetic NF-κB inhibitors could regulate IR-induced radioresistance and EMT in NSCLC cells with lower toxicity and fewer side effects. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.